In order to uncover the mechanisms involved in MTX-resistance in choriocarcinoma and the effect of LGALS3BP on the effectiveness of MTX treatment, we established MTX-resistant choriocarcinoma cells by gradual dose escalation of MTX, and found LGALS3BP was up-regulated in MTX-resistant cells compared to original cells. Here, LGALS3BP is linked to choriocarcinoma.